Muskoka Algonquin Healthcare and Huntsville Hospital Foundation are pleased to unveil a new, state-of-the-art Bone Mineral ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

Amgen said on Wednesday it does not see any bone safety concerns around the use of its experimental obesity drug, a day after ...

Supplementation with cholecalciferol 1000 IU/day during pregnancy is associated with greater offspring bone mineral density during childhood.

Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Patients with cystic fibrosis (CF) experience significant bone mineral density (BMD) loss at a younger age than those without the disease, with greater decline observed among individuals with ...

Navigating the changes that come with perimenopause and beyond can feel overwhelming, especially when it comes to ...

Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's stock has risen 4.6% this year against a decrease of 3.8% for the pharmaceuticals industry.

In Spain, 22.6% of women and 6.8% of men over 50 years old have osteoporosis, and forecasts predict a significant increase in ...

Lung transplant patients should undergo annual bone health screenings using dual-energy X-ray absorptiometry for the first ...

Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone ...